|
|
Neurology March 2009
Volume 72
Issue 10
| This week in Neurology(R) |
this week in neurology(r): highlights of the march 10 issue.
Pages: 867
|
| Editorials |
will tricyclic antidepressants make a comeback for depressed parkinson disease patients?.
- Okun, Michael, Fernandez, Hubert. Pages: 868-869
|
hepatitis vaccines and pediatric multiple sclerosis: does timing or type matter?.
- Ness, Jayne, MD, PhD, Bale, James. Pages: 870-871
|
| In Memoriam |
julius korein, md (1928-2008).
- Machado, Calixto, MD, PhD. Pages: 872
|
| Articles |
hepatitis b vaccine and the risk of cns inflammatory demyelination in childhood.
- Mikaeloff, Yann, MD, PhD, Caridade, Guillaume, Suissa, Samy, Tardieu, Marc, MD, PhD. Pages: 873-880
>
Show/Hide Abstract
Background: The risk of CNS inflammatory demyelination associated with hepatitis B (HB) vaccine is debated, with studies reporting conflicting findings.Methods: We conducted a population-based case-control study where the cases were children with a first episode of acute CNS inflammatory demyelination in France (1994-2003). Each case was matched on age, sex, and geographic location to up to 12 controls, randomly selected from the general population. Information on vaccinations was confirmed by a copy of the vaccination certificate. The odds ratios (ORs) of CNS inflammatory demyelination associated with HB vaccination were estimated using conditional logistic regression.Results: The rates of HB vaccination in the 3 years before the index date were 24.4% for the 349 cases and 27.3% for their 2,941 matched controls. HB vaccination within this period was not associated with an increase in the rate of CNS inflammatory demyelination (adjusted OR, 0.74; 0.54-1.02), neither >3 years nor as a function of the number of injections or brand type. When the analysis was restricted to subjects compliant with vaccination, HB vaccine exposure >3 years before index date was associated with an increased trend (1.50; 0.93-2.43), essentially from the Engerix B vaccine (1.74; 1.03-2.95). The OR was particularly elevated for this brand in patients with confirmed multiple sclerosis (2.77; 1.23-6.24).Conclusions: Hepatitis B vaccination does not generally increase the risk of CNS inflammatory demyelination in childhood. However, the Engerix B vaccine appears to increase this risk, particularly for confirmed multiple sclerosis, in the longer term. Our results require confirmation in future studies.GLOSSARY: ADEM = acute disseminated encephalomyelitis; BCG = Bacille Calmette-Guerin; HB = hepatitis B; MS = multiple sclerosis; OR = odds ratio.(C)2009AAN Enterprises, Inc.
|
pediatric optic neuritis: brain mri abnormalities and risk of multiple sclerosis.
- Bonhomme, G, Waldman, A, Balcer, L, MD, MSCE, Daniels, A, MD, MSc, Tennekoon, G, Forman, S, Galetta, S, Liu, G. Pages: 881-885
>
Show/Hide Abstract
Background: Optic neuritis is often the initial presentation of multiple sclerosis (MS). As established by the Optic Neuritis Treatment Trial, an abnormal baseline brain MRI is a strong predictor of MS after isolated optic neuritis in adults. However, the rate of conversion to MS after optic neuritis in children based upon brain MRI findings is unknown.Methods: We reviewed the medical records of children (<18 years) presenting with optic neuritis between 1993 and 2004 at the Children's Hospital of Philadelphia. Children with a history of demyelinating disease or prior optic neuritis were excluded. Symptoms, ophthalmologic findings, MRI findings, and clinical outcomes were recorded.Results: We identified 29 consecutive children with idiopathic optic neuritis. Eleven patients (38%) had white matter T2/FLAIR lesions in the brain (not including the optic nerves). Eighteen patients were followed for more than 24 months, and 3 of the 18 (17%) developed MS. All 3 patients had an abnormal brain MRI scan at their initial presentation of optic neuritis. None of the patients with a normal brain MRI scan at presentation developed MS over an average follow-up of 88.5 months. Patients with one or more white matter lesions on MRI were more likely to develop MS (3/7 vs 0/11, p = 0.04, Fisher exact test).Conclusions: Children with brain MRI abnormalities at the time of the diagnosis of optic neuritis have an increased risk of multiple sclerosis. Larger collaborative studies are needed to further define the prognosis for childhood optic neuritis.GLOSSARY: CHOP = Children's Hospital of Philadelphia; FLAIR = fluid-attenuated inversion recovery; MS = multiple sclerosis; NMO = neuromyelitis optica; ONTT = Optic Neuritis Treatment Trial.(C)2009AAN Enterprises, Inc.
|
a controlled trial of antidepressants in patients with parkinson disease and depression .
- Menza, M, Dobkin, R, Marin, H, Mark, M, Gara, M, Buyske, S, Bienfait, K, Dicke, A. Pages: 886-892
>
Show/Hide Abstract
Background: Parkinson disease (PD) is a common neurodegenerative disease affecting up to 1 million individuals in the United States. Depression affects up to 50% of these patients and is associated with a variety of poor outcomes for patients and their families. Despite this, there are few evidence-based data to guide clinical care.Methods: An NIH-funded, randomized, controlled trial of paroxetine CR, nortriptyline, and placebo in 52 patients with PD and depression. The primary outcomes were the change in the Hamilton Depression Rating Scale (HAM-D) and the percentage of depression responders at 8 weeks.Results: Nortriptyline was superior to placebo for the change in HAM-D (p < 0.002); paroxetine CR was not. There was a trend for superiority of nortriptyline over paroxetine CR at 8 weeks (p < 0.079). Response rates favored nortriptyline (p = 0.024): nortriptyline 53%, paroxetine CR 11%, placebo 24%. In planned contrasts of response rates, nortriptyline was superior to paroxetine CR (p = 0.034). Nortriptyline was also superior to placebo in many of the secondary outcomes, including sleep, anxiety, and social functioning, while paroxetine CR was not. Both active drug treatments were well tolerated.Conclusions: Though relatively modest in size, this is the largest placebo-controlled trial done to date in patients with Parkinson disease (PD) and depression. Nortriptyline was efficacious in the treatment of depression and paroxetine CR was not. When compared directly, nortriptyline produced significantly more responders than did paroxetine CR. The trial suggests that depression in patients with PD is responsive to treatment and raises questions about the relative efficacy of dual reuptake inhibitors and selective serotonin reuptake inhibitors.GLOSSARY: ARR = absolute risk reduction; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; HAM-A = Hamilton Anxiety Scale; HAM-D = Hamilton Depression Rating Scale; MMSE = Mini-Mental State Examination; NNT = number needed to treat; PD = Parkinson disease; PDQ = Parkinson's Disease Questionnaire; PSQI = Pittsburgh Sleep Quality Index; SCID = Structured Clinical Interview; SSRI = selective serotonin reuptake inhibitor; TCA = tricyclic antidepressant; UPDRS = Unified Parkinson's Disease Rating Scale.(C)2009AAN Enterprises, Inc.
|
acgme competencies in neurology: web-based objective simulated computerized clinical encounters.
- Kash, K, Leas, B, MS, MA, Clough, J, MD, MBA, Dodick, D, Capobianco, D, Nash, D, MD, MBA, Bance, L. Pages: 893-898
>
Show/Hide Abstract
Objective: The American Headache Society developed an innovative Web-based neurology resident educational program to 1) meet the objectives of the Accreditation Council for Graduate Medical Education Outcomes Project; 2) provide measurable improvement of a neurology resident's understanding of headache and the performance within each core competency; 3) assist residents and program directors in identifying knowledge gaps; and, ultimately, 4) improve the quality of patient care through enhanced educational initiatives.Methods: Quantitative analysis focused on pretest and post-test results, level attainment on case-based simulations, competency achievement, and interactions between cases. One of four validated global scores was related to each resident response on all competency learning opportunities and was measured, from one case to another, to determine improvement and understanding. The pretest and post-test each consisted of 50 randomized questions that tested baseline and improvement on specific core competencies and understanding of headache.Results: The pretest mean score was 30.08, and the post-test mean score was 34.79. A paired sample t test analysis showed a significant difference from pretest to post-test scores (M = -4.72, SD = 4.88, t[91] = -9.269, p < 0.001). There was significant improvement in the competencies as the residents moved through the cases as well as in each of the competencies from the pretest to the post-test. Results showed that residents increased their knowledge and performance by synthesizing the content.Conclusions: This outcomes analysis demonstrates the effectiveness of the American Headache Society Neurology Resident's Program in improving the resident's knowledge of headache medicine and Accreditation Council for Graduate Medical Education core competencies.GLOSSARY: ACGME = Accreditation Council for Graduate Medical Education; AHS = American Headache Society; GME = graduate medical education; NS = not significant; OSCCE = objective simulated computerized clinical encounter; PGY = postgraduate year.(C)2009AAN Enterprises, Inc.
|
prevalence of nephroangiosclerosis in patients with fatal stroke.
- Abboud, H, Labreuche, J, Duyckaerts, C, MD, PhD, Hauw, J-J, Amarenco, P. Pages: 899-904
>
Show/Hide Abstract
Background: Glomerular filtration rate and decline in renal function can be improved by global cardiovascular prevention. However, the prevalence of nephroangiosclerosis in patients with stroke is unknown.Methods: Using an autopsy data bank, we studied the prevalence of nephroangiosclerosis in 820 consecutive autopsies of neurologic patients.Results: Among the 820 autopsies, 354 had pathologic evidence of stroke and 466 had other neurologic diseases. Nephroangiosclerosis was found in 39.8% (95% confidence interval [CI], 34.7-44.9) of patients with stroke vs 9.0% (95% CI, 6.4-11.6) in patients with other neurologic diseases. The odds ratio (OR) for nephroangiosclerosis, adjusted for age and sex, was 4.37 (95% CI, 2.92-6.52), and was 2.94 (95% CI, 1.83-4.74) after further adjustment for cardiovascular risk factors. Among the 354 stroke patients, the prevalence of nephroangiosclerosis was similar in patients with brain infarction and in those with brain hemorrhage, in patients with or without parenchymal abnormalities related to small-vessel disease, and across ischemic stroke subtypes except for those with coexisting causes. After multivariable analysis, nephroangiosclerosis was independently associated with age and history of hypertension in patients with stroke, and with age in those with other neurologic diseases.Conclusions: Nephroangiosclerosis is common in patients with fatal stroke. The association is independent of age, sex, and other cardiovascular risk factors. Impaired renal function should be monitored and prevented in stroke patients with high blood pressure.GLOSSARY: CI = confidence interval; OND = neurologic diseases other than stroke; OR = odds ratio; SVD = small-vessel disease.(C)2009AAN Enterprises, Inc.
|
apathy: a major symptom in cadasil.
- Reyes, S, Viswanathan, A, MD, PhD, Godin, O, Dufouil, C, Benisty, S, Hernandez, K, Kurtz, A, Jouvent, E, O'Sullivan, M, MD, PhD, Czernecki, V, Bousser, M, Dichgans, M, MD, PhD, Chabriat, H, MD, PhD. Pages: 905-910
>
Show/Hide Abstract
Objective: The frequency and impact of apathy in subcortical ischemic vascular dementia (SIVD) remain undetermined. The frequency, clinical, neuropsychological, and imaging correlates of apathy were assessed in a large cohort of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, a genetic model of SIVD.Methods: Apathy was diagnosed based on Neuropsychiatric Inventory assessment. Degree of disability was assessed by modified Rankin scale, cognitive impairment by Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE), autonomy by the Instrumental Activities of Daily Living (IADL) scale, and quality of life by SEP-59 self-questionnaire. Validated imaging methods were used to determine the total burden of cerebral lesions.Results: Among 132 patients, 54 (41%) were apathetic. Apathetic patients were older than nonapathetic subjects, had a lower MMSE and MDRS score, had more global disability, and were more limited in IADL. Apathetic patients were more frequently depressed compared to nonapathetic patients and more frequently presented additional neuropsychiatric symptoms. Multiple regression modeling showed a significant and independent association between apathy and a lower score of overall quality of life and between apathy and a higher load of white matter and lacunar lesions.Conclusions: The results suggest that apathy is common in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), appears in association with cognitive impairment, global functional disability, and severe neuropsychiatric symptoms during the course of the disease, and can occur separately from depression. Apathy has an independent impact on the overall quality of life in CADASIL.GLOSSARY: CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; IADL = Instrumental Activities of Daily Living; ICC = intracranial cavity; LL = lacunar lesions; MDRS = Mattis Dementia Rating Scale; MMSE = Mini-Mental State Examination; mRS = modified Rankin scale; NA = not applicable because of insufficient observations; nCM = number of cerebral microhemorrhages; nLL = normalized volume of lacunar lesions; NPI = Neuropsychiatric Inventory; nWMH = normalized volume of white matter hyperintensities; QOL = quality of life; SIVD = subcortical ischemic vascular dementia; TIA = transient ischemic attack; WMH = white matter hyperintensities.(C)2009AAN Enterprises, Inc.
|
valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use.
- Herzog, A, MD, MSc, Blum, A, MD, PhD, Farina, E, Maestri, X, Newman, J, Garcia, E, Krishnamurthy, K, Hoch, D, Replansky, S, Fowler, K, Smithson, S, Dworetzky, B, Bromfield, E. Pages: 911-914
>
Show/Hide Abstract
Objective: To determine whether 1) combined oral contraceptive (COC) use affects serum levels of valproate (VPA) as well as lamotrigine (LTG) and 2) the naturally occurring high (mid-luteal) and low (early-mid follicular) reproductive steroid level phases of the menstrual cycle might affect antiepileptic drug levels as well.Methods: This investigation compared serum antiepileptic drug levels at two timepoints during a single menstrual cycle in four groups of women with epilepsy: 12 on VPA, 12 on VPA plus COC (VPA-COC), 12 on LTG, and 12 on LTG plus COC (LTG-COC).Results: Both VPA and LTG levels were lower (p < 0.01) on active COC than on inactive pill with median declines of 23.4% for the VPA-COC group and 32.6% for the LTG-COC group. Serum LTG levels showed a notable but not significant 31.3% median decline during the mid-luteal phase compared to the early-mid follicular phase in the non-COC group. The non-COC valproate group showed the least change of any group between the two measured timepoints with a decline of 8.3% (p = NS).Conclusions: The findings suggest that valproate (VPA), like lamotrigine (LTG), has substantially and significantly lower serum levels while women take active combined oral contraceptives as compared to inactive pills. Larger sample sizes will be required to determine whether LTG levels may drop significantly also during the luteal (high steroid) phase of natural menstrual cycles and whether VPA levels may show greater stability in levels across the phases of the menstrual cycle.GLOSSARY: AED = antiepileptic drug; BMI = basal metabolic index; COC = combined oral contraceptive; EIAED = enzyme-inducing antiepileptic drug; IGE = idiopathic generalized epilepsy; LRE = localization-related epilepsy; LTG = lamotrigine; VPA = valproate.(C)2009AAN Enterprises, Inc.
|
acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
- Parsons, M, PhD, FRACP, Miteff, F, Bateman, G, Spratt, N, PhD, FRACP, Loiselle, A, Attia, J, PhD, FRACP, Levi, C. Pages: 915-921
>
Show/Hide Abstract
Background: Tenecteplase is a modified tissue plasminogen activator with a longer half-life and higher fibrin specificity than alteplase.Methods: We conducted a prospective, nonrandomized, pilot study of 0.1 mg/kg IV tenecteplase given 3 to 6 hours after ischemic stroke onset. For a control group, we used patients contemporaneously treated with sub-3-hour 0.9 mg/kg IV alteplase following standard selection criteria. All patients underwent pretreatment and 24-hour perfusion/angiographic imaging with CT or MRI. Eligibility criteria for tenecteplase (but not alteplase) treatment included a perfusion lesion at least 20% greater than the infarct core, with an associated vessel occlusion. Primary outcomes, assessed blind to treatment group, were reperfusion (reduction in baseline-24-hour mean transit time lesion) and major vessel recanalization.Results: Fifteen patients received tenecteplase, and 35 patients received alteplase. The tenecteplase group had greater reperfusion (mean 74% vs 44% in the alteplase group, p = 0.01) and major vessel recanalization (10/15 tenecteplase vs 7/29 alteplase, p = 0.01). Despite later time to treatment, more tenecteplase patients (10/15 vs 7/35 alteplase, p = 0.001) had major neurologic improvement at 24 hours (NIH Stroke Scale reduction >=8). Four of the alteplase patients and none of the tenecteplase patients had parenchymal hematoma at 24 hours.Conclusions: Tenecteplase 0.1 mg/kg, using advanced imaging guidance in an extended time window, may have significant biologic efficacy in acute ischemic stroke. The imaging selection differences between the tenecteplase and alteplase groups prevent a conclusive efficacy comparison. Nonetheless, these results lend support for randomized trials comparing tenecteplase with alteplase, preferably incorporating penumbral/angiographic imaging selection.GLOSSARY: CBV = cerebral blood volume; CTA = CT angiography; CTP = perfusion CT; DWI = diffusion-weighted echo-planar spin-echo sequence; ICH = intracranial hemorrhage; MNI = major neurologic improvement; MR = magnetic resonance; mRS = modified Rankin Scale; MTT = mean transit time; NCCT = noncontrast CT; NIHSS = NIH Stroke Scale; PH = parenchymal hematoma; TIMI = Thrombolysis in Myocardial Infarction.(C)2009AAN Enterprises, Inc.
|
weather and air pollution as triggers of severe headaches.
- Mukamal, Kenneth, Wellenius, Gregory, Suh, Helen, Mittleman, Murray, MD, DrPH. Pages: 922-927
>
Show/Hide Abstract
Background: The roles of weather conditions and air pollution as triggers of headache have been inconsistent in previous, generally small studies.Methods: We performed a case-crossover study of 7,054 patients seen in a single emergency department between May 2000 and December 2007 with a primary discharge diagnosis of headache. We compared levels of temperature, barometric pressure, humidity, fine particulate matter, black carbon, and nitrogen and sulfur dioxides during the three 24-hour periods preceding presentation with corresponding levels on the remaining occurrences of that day of the week in a given month, using local meteorologic and pollutant monitors.Results: Higher mean ambient temperature in the 24 hours preceding hospital presentation positively and linearly increased the acute risk of headache (odds ratio [OR] for a 5[degrees]C increment 1.075; 95% confidence interval [CI], 1.021-1.033; p = 0.006). Higher risk was observed for cases with and without a discharge diagnosis of migraine and for cases between October and March or between April and September. Lower barometric pressure also increased the risk of nonmigraine cases in the 48 to 72 hours before hospitalization (OR 0.939 per 5 mm Hg; 95% CI, 0.902-0.978; p = 0.002). Current levels of pollutants did not influence the risk of headache.Conclusions: Higher ambient temperature and, to a lesser degree, lower barometric pressure led to a transient increase in risk of headache requiring emergency department evaluation. We did not find clear association of air pollutants with risk, but cannot exclude effects of air pollution of the magnitude previously observed for stroke and other cardiovascular events.GLOSSARY: BC = black carbon; BIDMC = Beth Israel Deaconess Medical Center; CI = confidence interval; OR = odds ratio; PM2.5 = fine particulate matter with aerodynamic diameter <=2.5 [mu]m.(C)2009AAN Enterprises, Inc.
|
mild cognitive impairment: loss of linguistic task-induced changes in motor cortex excitability.
- Bracco, L, Giovannelli, F, Bessi, V, Borgheresi, A, Di Tullio, A, Sorbi, S, Zaccara, G, Cincotta, M. Pages: 928-934
>
Show/Hide Abstract
Background: In amnestic mild cognitive impairment (aMCI), functional neuronal connectivity may be altered, as suggested by quantitative EEG and neuroimaging data. In young healthy humans, the execution of linguistic tasks modifies the excitability of the hand area of the dominant primary motor cortex (M1hand), as tested by transcranial magnetic stimulation (TMS). We used TMS to investigate functional connectivity between language-related cortical areas and M1hand in aMCI.Methods: Ten elderly women with aMCI and 10 age-matched women were recruited. All participants were right handed and underwent a neuropsychological evaluation. In the first TMS experiment, participants performed three different tasks: reading aloud, viewing of non-letter strings (baseline), and nonverbal oral movements. The second experiment included the baseline condition and three visual searching/matching tasks using letters, geometric shapes, or digits as target stimuli.Results: In controls, motor evoked potentials (MEP) elicited by suprathreshold TMS of the left M1hand were significantly larger during reading aloud (170% baseline) than during nonverbal oral movements, whereas no difference was seen for right M1hand stimulation. Similarly, MEP elicited by left M1hand stimulation during letter and shape searching/matching tasks were significantly larger compared to digit task. In contrast, linguistic task performance did not produce any significant MEP modulation in patients with aMCI, although neuropsychological evaluation showed normal language abilities.Conclusions: Findings suggest that functional connectivity between the language-related brain regions and the dominant M1hand may be altered in amnestic mild cognitive impairment. Follow-up studies will reveal whether transcranial magnetic stimulation application during linguistic tasks may contribute to characterize the risk of conversion to Alzheimer disease.GLOSSARY: AD = Alzheimer disease; aMCI = amnestic mild cognitive impairment; ANOVA = analysis of variance; FDI = first dorsal interosseous; M1 = primary motor cortex; MEP = motor evoked potentials; MMSE = Mini-Mental State Examination; pvIQ = premorbid verbal intelligence; RMT = resting motor threshold; TMS = transcranial magnetic stimulation.(C)2009AAN Enterprises, Inc.
|
| Clinical/Scientific Notes |
a case of acute polyradiculoneuropathy, drug-induced hypersensitivity, and hhv-6 infection.
- Del Borgo, C, Zaniratti, S, Minosse, C, Vetica, A, Bellini, A, Soscia, F, Missori, P, Pierelli, F, Curra, A, MD, PhD. Pages: 935-936
|
trigeminal nerve stimulation for epilepsy: long-term feasibility and efficacy.
- DeGiorgio, Christopher, Murray, Diana, Markovic, Daniela, Whitehurst, Todd. Pages: 936-938
|
| Reflections: Neurology and the Humanities |
guns in the afternoon.
- Gutmann, Ludwig. Pages: 939-941
|
| Neuroimages |
corpus callosum dysgenesis limits mri changes to one hemisphere in status epilepticus.
- Grommes, Christian, Oghlakian, Roger, Blackham, Kristina, De Georgia, Michael. Pages: 942
|
| Resident & Fellow Section |
teaching neuroimages: cerebral arteriovenous malformation in hereditary hemorrhagic telangiectasia.
- Pikula, Aleksandra, Almodovar, Jorge, Nguyen, Thanh. Pages: e45
|
international issues: educational programs of the world federation of neurology.
- Munsat, T, Aarli, J, Medina, M, Birbeck, G, Weiss, A. Pages: e46-e49
|
| Correspondence |
epilepsy-associated bone mineral density loss should be prevented.
- Mikati, Mohamad, Ataya, Nour, El-Hajj Fuleihan, Ghada. Pages: 943-944
|
dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
- Yoshii, Y, Ikeda, K, Iwamoto, K, Kawase, Y, Iwasaki, Y. Pages: 944-945
|
| Departments: Calendar |
calendar.
Pages: 946-947
|
| Future Issues |
in the next issue of neurology(r): volume 72, number 11, march 17, 2009.
Pages: 38A
|
|
|